Company news

Benitec Biopharma Inc. news in 2021

Benitec Biopharma Inc.'s news releases, calls and decks from 2021, newest first.

View company

Benitec Biopharma Discloses Q1 2022 Financial Results

November 14, 2021

Benitec Biopharma Provides Operational Update and Releases its 2021 Fiscal Year-End Financial Results

September 19, 2021

Benitec Biopharma to present at H.C. Wainwright's 23rd Annual Global Investment Conference

September 12, 2021

Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in Large Animals

September 7, 2021

Benitec Biopharma Provides Positive Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022

September 7, 2021

Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial Design for 2022

September 7, 2021

Benitec Biopharma Increases Previously Announced Bought Deal Offering of Common Stock to $12.9 Million

April 26, 2021

Benitec Biopharma Announces $7.5 Million Bought Deal Offering of Common Stock

April 26, 2021

Benitec Biopharma Announces Successful Results from the Interim Analysis of the BB-301 Pilot Dosing Study

February 23, 2021

Decks in 2021